Charoen Pokphand Foods: Management expects swine prices to improve in 2H26, UBS maintains Neutral rating

Overview

This report is based on UBS's observations after attending Charoen Pokphand Foods (CPF)'s 1Q26 analyst meeting. The core conclusion is that management remains cautiously optimistic about an improvement in swine prices in 2H26. Thailand's hog supply may gradually tighten in the second half of the year due to seasonal heat, potential disease concerns, and government efforts to constrain supply; however, disease-related herd clearing in the near term will add supply to the market and may still weigh on prices. The company's international businesses are diverging clearly: China remains under pressure from oversupply and profitability weakness, while Vietnam is recovering faster as regulations tighten and small farms exit.

Core views

UBS keeps a Neutral rating on CPF, arguing that the valuation is about 8x 2026E earnings, broadly in line with the Thai consumer sector average. Positive factors include a recovery in Thailand swine prices in 2H26, resilient chicken export demand, tighter supply in Vietnam, and the potential listing of CP Vietnam. Constraints include near-term swine price pressure, China's oversupply, rising raw material costs, and relatively high financial leverage. Overall, the direction of fundamental improvement is clear, but earnings leverage and valuation upside still depend on a clearer turning point in prices and costs.

Analysis framework

The report mainly analyzes management meeting feedback, regional supply-demand changes, swine price and chicken export trends, company financial forecasts, valuation multiples, and UBS's target price framework. The valuation uses a sum-of-the-parts approach, in which the core business is valued using DCF and CP All equity is included at current market value.

Methodology notes

• Valuation methodsSOTP

  Sum-of-the-parts valuation

  UBS values CPF's core business and its CP All stake separately, using DCF for the core business and current market value for the equity investment.

• Valuation methodsDCF

  Discounted cash flow

  The report says the target price is based on DCF and gives a 12-month target price of Bt21.00.

• RatingUBS Forecast Stock Return

  Forecast stock return

  UBS defines forecast stock return as the expected share price upside over the next 12 months plus dividend yield; in this report, the forecast share price upside is 10.5%, the forecast dividend yield is 4.8%, and the forecast stock return is 15.3%.

• RatingMarket Return Assumption

  Market return assumption

  UBS defines market return assumption as the one-year local market rate plus 5%; this report shows a market return assumption of 7.0% and a forecast excess return of 8.3%.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Charoen Pokphand Foods

  Research coverage

  Strengths

  An integrated agribusiness platform covering feed, farming, commercial farms, and meat processing; chicken export demand remains resilient; supply tightening in Thailand and Vietnam supports price improvement.

  Weaknesses

  Near-term swine prices are pressured by disease-related herd clearing, China's business still suffers from oversupply, and net debt/EBITDA is high.

  Comparison

  CPF trades at about 8x 2026E P/E, which the text says is in line with the Thai consumer sector average.

  Risks

  Rising raw material prices, falling livestock prices, Thai baht appreciation, weaker meat demand, export bans, higher interest rates, disease outbreaks, and natural disasters.

• CP Vietnam

  Subsidiary and potential IPO asset

  Strengths

  Tighter regulation in Vietnam is removing non-compliant small farms, supply is tightening, business recovery is faster, and the IPO is expected to move forward by the end of 2026 or early 2027.

  Weaknesses

  The listing timing still depends on market conditions and regulatory progress.

  Comparison

  Vietnam's recovery trend is more positive than China's business trend.

  Risks

  Regulatory changes, livestock cycle volatility, disease risk, and changes in the IPO window.

• CP All

  Equity investment valuation component

  Strengths

  UBS includes this stake at current market value in the SOTP, which helps reflect non-core business value.

  Weaknesses

  The equity value is subject to market price volatility.

  Comparison

  The core business is valued using DCF, while the CP All stake is valued at current market value.

  Risks

  Market valuation volatility and liquidity risk.

Key data

• 12-month ratingNeutralThe company disclosure sheet shows Charoen Pokphand Foods rated Neutral.
• 12-month target priceBt21.00The target price is listed on the report cover.
• Disclosed priceBt19.00The price date is 2026-05-15.
• Forecast share price upside10.5%Shown in the forecast return table.
• Forecast dividend yield4.8%Shown in the forecast return table.
• Forecast total stock return15.3%The forecast share price upside and dividend yield combined.
• 2026E P/E8.4xThe chart shows 2026E PE (UBS diluted) at 8.4x; the text says about 8x and that it is in line with the Thai consumer sector average.
• 2026E EPSBt2.27UBS diluted EPS forecast.
• 2026E EBITBt38,771mShown in the financial summary table.
• 2026E net profitBt17,525mUBS net profit forecast.
• Market capBt148b / US$4.59bShown in the trading data and key metrics table.
• 2026E net debt/EBITDA6.9xShown in the trading data and key metrics table, indicating a relatively high leverage level.

Impact & implications

The main implication for investment judgment is that CPF's earnings recovery requires three things at the same time: a rebound in swine prices, realized supply tightening, and controlled raw material costs. If Thailand swine prices improve as expected in 4Q26 and US corn imports ease cost pressure in 2027, margins could recover; however, if disease-driven early slaughter continues, raw material inflation outpaces meat price recovery, or China's capacity reduction falls short of expectations, valuation upside will remain limited. The Neutral rating reflects the balance between expected fundamental improvement and near-term earnings uncertainty.

Risks

• Rising corn, soybean meal, and other raw material prices could compress margins.
• Livestock prices may fall short of expectations, especially if swine prices in Thailand or China recover less than expected.
• Thai baht appreciation could hurt export competitiveness and profit performance.
• Weaker meat demand or slower-than-expected consumption recovery.
• Export bans or trade restrictions could affect chicken and meat exports.
• Higher interest rates may increase financing costs.
• Animal disease outbreaks could disrupt supply, prices, and farming profits.
• Natural disasters could affect farming and supply chains.
• Plant-based meat trends may create long-term pressure on conventional meat demand.

What to watch

• Whether Thailand swine prices improve in 2H26 as management expects, especially in 4Q26.
• Whether disease-related early slaughter continues to pressure near-term swine prices.
• The strength and effectiveness of Thailand's efforts to cull piglets and constrain supply.
• Whether China's hog capacity cuts bring price improvement by the end of 2026.
• The contribution of tighter supply in Vietnam to profit recovery, and whether the CP Vietnam IPO is completed by the end of 2026 or early 2027.
• Demand resilience for chicken in Japan and other export markets.
• The trend in raw material costs such as corn and soybean meal, and the extent to which US corn imports ease margin pressure in 2027.